LiDCO CEO retires after 24 years
This article was originally published in Clinica
Terry O’Brien is retiring as CEO of LiDCO after leading the UK hemodynamic monitoring company for 24 years. Dr O’Brien’s successor is Matthew Sassone, who is currently chief marketing officer of Maquet, a division of Getinge. Mr Sassone will assume the role of director and CEO Designate on 15 June, while he works with Dr O’Brien on the handover. His appointment as CEO and Dr O’Brien’s retirement are expected to take place on 17 August. Mr Sassone’s experience is mainly in sales, marketing and business development; prior to Maquet, he has worked at Smiths Medical and ArjoHuntleigh, another division of Getinge.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.